Evidence map›Paper›PMID 37375026›Full record

ArticleMicroorganisms2023

Isolation and Characterization of Jumbo Coliphage vB_EcoM_Lh1B as a Promising Therapeutic Agent against Chicken Colibacillosis.

Pavel Alexyuk, Andrey Bogoyavlenskiy, Madina Alexyuk, Kuralay Akanova, Yergali Moldakhanov, Vladimir Berezin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Isolation of Lytic Bacteriophages ofVeterinary sciences · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pavel AlexyukLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.ORCID 0000-0003-3638-3341
Andrey BogoyavlenskiyLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.
Madina AlexyukLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.
Kuralay AkanovaLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.
Yergali MoldakhanovLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.
Vladimir BerezinLaboratory of Antiviral Protection, Department of Virology, Research and Production Center for Microbiology and Virology, Bogenbai Batyr Street 105, Almaty 050010, Kazakhstan.

Funding

Ministry of Education and Science of the Republic of Kazakhstan AP09058580, AP14870277.
6 · The paper itself

Abstract

Colibacillosis in chickens can cause the death of young stock, decrease weight gain and lead to significant economic losses. Currently, antibiotic therapy is the main method of treatment of infected animals, but unchecked use of antibiotics has led to widespread antibiotic resistance among microorganisms. Therefore, it is necessary to develop alternative methods of treating bacterial infections that are fully consistent with the One Health concept and introduce them into practice. Phage therapy meets the specified requirements perfectly. This study describes the isolation and characterization of the lytic jumbo phage vB_EcoM_Lh1B and evaluates its potential use in controlling antibiotic-resistant

Indexed as

antibiotic resistancebacteriophagecolibacillosisEscherichia colipoultry farming

Identifiers

PMID37375026
PMCPMC10302289
OpenAlexW4380049499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.